Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEland Oil & Gas Regulatory News (ELA)

  • There is currently no data for ELA

Opuama-3 Workover Update

25 Apr 2016 11:51

RNS Number : 2233W
Eland Oil & Gas PLC
25 April 2016
 

 

 

 

25 April 2016

 

Eland Oil & Gas PLC

 ("Eland" or the "Company")

 

Opuama-3 Workover Update

 

Eland Oil & Gas PLC (AIM: ELA), an oil & gas production and development company operating in West Africa, with an initial focus on Nigeria, is pleased to announce that, its joint-venture subsidiary Elcrest Exploration and Production Nigeria Ltd together with NPDC, its partner on OML 40, has completed the perforation of two new intervals in the Opuama-3 well and increased production from the two strings. Following the operational update on the Opuama-3 well re-entry announced on 14 April 2016 the following operation highlights have taken place on Opuama Field:

 

· Following the Production Logging Tool (PLT) runs in both strings of the Opuama 3 well the water ingress was identified to be coming from the lower D5000 producing interval. The D5000 reservoir was subsequently isolated by placing a cement plug across the interval with a coiled tubing intervention.

· Oriented perforations were shot into the D1000 upper reservoir in the Long String and into the D2000 reservoir in the Short String.

· Both strings were produced to a storage barge and flow rate tested.

· The Short String flowed for 6 hours on a 48/64" choke and produced 1,137 bbls of oil. This extrapolates to 4,548 barrels of dry crude per day.

· The Long String flowed for 1 hour on a 48/64" choke and produced 235 barrels of oil. This extrapolates to 5,640 barrels of dry crude per day.

· The successful cement job has removed over an estimated 1,000 barrels of water production from the well, significantly reducing the well's water cut.

· The combined flow from both strings was tested for 1 hour on 48/64" choke and produced 441 barrels of oil. This extrapolates to 10,584 barrels of dry crude per day from Opuama-3.

· Following the re-opening of the Forcados terminal, which we currently expect within a month, we then expect to recommence production from Opuama flowstation.

 

 

George Maxwell, CEO of Eland, commented:

 

"We are very pleased to announce the successful completion of the Opuama-3 re-entry and the strong results from flow testing the well. The results are beyond the high end of our previously announced expected range of 2,000-4,000 incremental gross barrels of oil produced per day. The two newly perforated reservoirs have proven to be highly productive. The initial combined flow rate from Opuama-3 well of 10,584 barrels of oil per day will move on normalised production, but will still be well in excess of our previous forecast.

 

Following this significant success we now move our focus to the Gbetiokun-1 workover well, also on licence OML 40. Our current plan is to commence operations on this high quality asset in the second half of the year, and we anticipate that a successful workover will lead to our current forecast of gross production in the range of 5,000-10,000 barrels of oil per day from the Gbetiokun-1 well"

 

 

 

For further information:

 

Eland Oil & Gas PLC (+44 (0)1224 737300)

www.elandoilandgas.com

George Maxwell, CEO

Louis Castro, CFO

Finlay Thomson, IR

 

Canaccord Genuity Limited (+44 (0)20 7 523 8000)

Henry Fitzgerald O'Connor

 Nilesh Patel

 

In accordance with the guidelines of the AIM Market of the London Stock Exchange, John Downey, a geologist and Eland's Chief Technical Officer, who has a BSc from Nottingham University, an MSc from Leeds University and has over 30 years of relevant experience in the upstream oil and gas industry and who is a member of the Society of Petroleum Engineers and meets the criteria of qualified person under the AIM guidance note for mining and oil and gas companies, has reviewed and approved the technical information contained in this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSEAFSIFMSELL
Date   Source Headline
15th Nov 20062:50 pmRNSAnnual Report
25th Oct 20062:18 pmRNSBlocklisting Interim Review
25th Oct 20067:30 amBUSElan Reports Third Quarter 2006 Financial Results
24th Oct 20061:00 pmBUSTYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe Crohn's Disease Treated for Longer Than Two Years According to Data Presented This Week
18th Oct 20068:42 amRNSHolding in Company
10th Oct 20067:00 amBUSNotice of Results
6th Oct 20062:07 pmBUSNew Pharmacoeconomic Data on TYSABRI(R) Demonstrate Significant Reduction in Steroid Use and Hospitalizations in Patients with Multiple Sclerosis
4th Oct 20061:00 pmBUSHealth Canada Grants Approval of TYSABRI(TM) (natalizumab) for the Treatment of Multiple Sclerosis Following Priority Review
29th Sep 20062:00 pmBUSNew Data Presented at ECTRIMS Congress Show TYSABRI(R) Has Sustained Effect on Relapse Rate in Multiple Sclerosis Patients Treated for up to Three Years
11th Sep 200611:57 amRNSFinancial Statements
9th Aug 20068:58 amRNSHolding in Company
2nd Aug 20065:26 pmRNSDirector/PDMR Shareholding
2nd Aug 200612:12 pmRNSHolding in Company
29th Jun 200612:32 pmRNSHolding in Company
21st Jun 200610:01 amRNSHolding in Company
15th Jun 20068:20 amRNSHolding in Company
7th Jun 20068:02 amRNSFurther re Appointment
1st Jun 200611:58 amRNSHolding in Company
25th May 20063:31 pmRNSHolding in Companies
25th May 200612:37 pmRNSHolding in Company
19th May 20065:51 pmRNSDirectors/PDMR Shareholding
19th May 200610:56 amRNSHolding in Company
17th May 200612:16 pmRNSHolding in Company
12th May 20061:45 pmRNSDirector/PDMR Shareholding
24th Apr 200611:36 amRNSHolding in Company
20th Apr 20064:44 pmRNSDocument Availability
19th Apr 20063:30 pmRNSHolding in Company
13th Apr 200612:51 pmRNSHolding in Company
13th Apr 200612:04 pmRNSAnnual Information Update
10th Apr 200612:42 pmRNSBrochure of Particulars
3rd Apr 20063:39 pmRNSBrochure of Particulars
13th Mar 200611:47 amRNSHoldings in Company
10th Mar 20063:24 pmRNSDirector/PDMR Shareholding
9th Mar 20067:30 amRNSRestoration of Listing
9th Mar 20067:01 amRNSOL Notice - Restoration
7th Mar 20061:00 pmRNSSuspension - Elan Corp Plc
7th Mar 20061:00 pmRNSOL Notice - Suspension
15th Feb 200610:15 amRNSBrochure of Particulars
10th Feb 20064:55 pmRNSDirector/PDMR Shareholding
9th Feb 20065:32 pmRNSDirector/PDMR Shareholding
9th Feb 20063:54 pmRNSHolding in Company
8th Feb 200610:56 amRNSDirector/PDMR Shareholding
3rd Feb 20069:58 amRNSDirector/PDMR Shareholding
25th Jan 200611:19 amRNSHolding in Company
9th Dec 20054:02 pmRNSDirector/PDMR Shareholding
17th Nov 20052:31 pmRNSRE:Director/PDMR Shareholding
1st Nov 20055:32 pmRNSDirector/PDMR Shareholding
22nd Sep 20059:43 amRNSRe: Brochure of Particulars
23rd Aug 20055:12 pmRNSDirector/PDMR Shareholding
21st Jun 200511:32 amRNSBrochure of Particulars

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.